Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Open Biosystems was a life science company specializing in genomic research tools, particularly RNA interference (RNAi) and gene expression resources. The company provided extensive libraries of shRNA, cDNA, and ORF clones to the global research community, facilitating functional genomics studies. Founded in 2001 and based in Huntsville, Alabama, it became a leading provider of viral-based delivery systems for gene knockdown. In 2008, the company was acquired by Thermo Fisher Scientific for approximately $42 million. Following the acquisition, its products were integrated into the Thermo Scientific Dharmacon and Molecular Biology portfolios.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Open Biosystems.